Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

G. Chong · SciRah

Researcher profile · Semantic Scholar

G. Chong

Share profile

G. Chong — researcher profile on SciRah

h-index: 24
Works: 106
Citations: 2,097

Most-cited papers

Mucinous histology predicts for reduced fluorouracil responsiveness and survival in advanced colorectal cancer.
F. Negri, A. Wotherspoon, D. Cunningham, A. Norman +2 more
2005Annals of Oncology159 citations Open access
Semantic Scholar
A Phase I Trial of Humanized Monoclonal Antibody A33 in Patients with Colorectal Carcinoma: Biodistribution, Pharmacokinetics, and Quantitative Tumor Uptake
A. Scott, F. Lee, Robert M. Jones, W. Hopkins +19 more
2005Clinical Cancer Research122 citations Open access
Semantic Scholar
Dual targeting of the epidermal growth factor receptor using the combination of cetuximab and erlotinib: preclinical evaluation and results of the phase II DUX study in chemotherapy-refractory, advanced colorectal cancer.
A. Weickhardt, T. Price, G. Chong, V. Gebski +10 more
2012Journal of Clinical Oncology109 citations Open access
Semantic Scholar
Gemcitabine, cisplatin and methylprednisolone for the treatment of patients with peripheral T-cell lymphoma: the Royal Marsden Hospital experience.
H. Arkenau, G. Chong, D. Cunningham, D. Watkins +6 more
2007Haematologica100 citations Open access
Semantic Scholar
The role of intrathecal chemotherapy prophylaxis in patients with diffuse large B-cell lymphoma.
H. Arkenau, G. Chong, David Cunningham, D. Watkins +6 more
2007Annals of Oncology87 citations Open access
Semantic Scholar
A Phase I Biodistribution and Pharmacokinetic Trial of Humanized Monoclonal Antibody Hu3s193 in Patients with Advanced Epithelial Cancers that Express the Lewis-Y Antigen
A. Scott, N. Tebbutt, F. Lee, T. Cavicchiolo +16 more
2007Clinical Cancer Research74 citations Open access
Semantic Scholar
Phase I Trial of 131I-huA33 in Patients with Advanced Colorectal Carcinoma
G. Chong, F. Lee, W. Hopkins, N. Tebbutt +18 more
2005Clinical Cancer Research73 citations
Semantic Scholar
Programmed cell death-1 inhibition in lymphoma.
E. Hawkes, A. Grigg, G. Chong
2015The Lancet Oncology71 citations
Semantic Scholar
Capecitabine and mitomycin C as third-line therapy for patients with metastatic colorectal cancer resistant to fluorouracil and irinotecan
G. Chong, J. Dickson, David Cunningham, A. Norman +5 more
2005British Journal of Cancer71 citations Open access
Semantic Scholar
Longitudinal Assessment of Quality of Life in Rectal Cancer Patients With or Without Stomas Following Primary Resection
T. Yau, D. Watkins, D. Cunningham, Y. Barbáchano +2 more
2009Diseases of the Colon & Rectum69 citations
Semantic Scholar
Prognostication of diffuse large B-cell lymphoma in the molecular era: moving beyond the IPI.
J. Wight, G. Chong, A. Grigg, E. Hawkes
2018Blood reviews66 citations
Semantic Scholar
Single-agent activity of phosphatidylinositol 3-kinase inhibition with copanlisib in patients with molecularly defined relapsed or refractory diffuse large B-cell lymphoma
G. Lenz, E. Hawkes, G. Verhoef, C. Haioun +15 more
2020Leukemia59 citations Open access
Semantic Scholar
Early treatment intensification with R-ICE and 90Y-ibritumomab tiuxetan (Zevalin)-BEAM stem cell transplantation in patients with high-risk diffuse large B-cell lymphoma patients and positive interim PET after 4 cycles of R-CHOP-14
M. Hertzberg, M. Gandhi, J. Trotman, B. Butcher +20 more
2017Haematologica58 citations Open access
Semantic Scholar
The prognostic role of WHO classification, urinary 5-hydroxyindoleacetic acid and liver function tests in metastatic neuroendocrine carcinomas of the gastroenteropancreatic tract
V. Formica, A. Wotherspoon, D. Cunningham, A. Norman +3 more
2007British Journal of Cancer56 citations Open access
Semantic Scholar
Improving long-term outcomes for patients with liver metastases from colorectal cancer.
G. Chong, D. Cunningham
2005Journal of Clinical Oncology54 citations Open access
Semantic Scholar
Clinical, Pharmacodynamic, and Pharmacokinetic Evaluation of BNC105P: A Phase I Trial of a Novel Vascular Disrupting Agent and Inhibitor of Cancer Cell Proliferation
D. Rischin, D. Bibby, G. Chong, G. Kremmidiotis +5 more
2011Clinical Cancer Research51 citations Open access
Semantic Scholar
Novel Indications for Bruton’s Tyrosine Kinase Inhibitors, beyond Hematological Malignancies
R. Campbell, G. Chong, E. Hawkes
2018Journal of Clinical Medicine50 citations Open access
Semantic Scholar
Concurrent ibrutinib plus venetoclax in relapsed/refractory mantle cell lymphoma: the safety run-in of the phase 3 SYMPATICO study
Michael L. Wang, R. Ramchandren, Robert W. Chen, Lionel Karlin +11 more
2021Journal of Hematology & Oncology46 citations Open access
Semantic Scholar
Phase I Imaging and Pharmacodynamic Trial of CS-1008 in Patients With Metastatic Colorectal Cancer.
M. Ciprotti, N. Tebbutt, F. Lee, Sze T. Lee +18 more
2015Journal of Clinical Oncology41 citations Open access
Semantic Scholar
A phase II trial evaluating capecitabine and irinotecan as second line treatment in patients with oesophago-gastric cancer who have progressed on, or within 3 months of platinum-based chemotherapy
A. Leary, L. Assersohn, David Cunningham, A. Norman +6 more
2009Cancer Chemotherapy and Pharmacology38 citations
Semantic Scholar
A pilot study of monoclonal antibody cG250 and low dose subcutaneous IL-2 in patients with advanced renal cell carcinoma.
I. Davis, Zhan-Qi Liu, W. Saunders, F. Lee +11 more
2007Cancer Immunity37 citations
Semantic Scholar
Phase III trial of 5-fluorouracil and leucovorin plus either 3H1 anti-idiotype monoclonal antibody or placebo in patients with advanced colorectal cancer.
G. Chong, A. Bhatnagar, David Cunningham, T. Cosgriff +14 more
2006Annals of Oncology33 citations Open access
Semantic Scholar
Gastrointestinal cancer: recent developments in medical oncology.
G. Chong, D. Cunningham
2005European Journal of Surgical Oncology26 citations
Semantic Scholar
Comprehensive geriatric assessment is useful in an elderly Australian population with diffuse large B‐cell lymphoma receiving rituximab‐chemotherapy combinations
D. M. Ong, M. Ashby, A. Grigg, G. Gard +9 more
2019British Journal of Haematology22 citations Open access
Semantic Scholar
Mortality within 30 days of receiving systemic anti‐cancer therapy at a regional oncology unit: What have we learned?
J. Yoong, J. Seah, K. Hamilton, Lee-Na Teo +1 more
2012Asia-Pacific Journal of Clinical Oncology22 citations
Semantic Scholar
Evolution of eligibility criteria for diffuse large B‐cell lymphoma randomised controlled trials over 30 years
Z. Loh, R. Salvaris, G. Chong, L. Churilov +3 more
2021British Journal of Haematology21 citations Open access
Semantic Scholar
Hodgkin lymphoma: an Australian experience of ABVD chemotherapy in the modern era
A. Jalali, F. Ha, G. Chong, A. Grigg +5 more
2016Annals of Hematology20 citations
Semantic Scholar
Safety and Efficacy of Induction and Maintenance Avelumab Plus R-CHOP in Patients with Diffuse Large B-Cell Lymphoma (DLBCL): Analysis of the Phase II Avr-CHOP Study
E. Hawkes, G. Chong, Charmaine D. Smith, Sze T. Lee +15 more
202017 citations Open access
Semantic Scholar
Phase I Trial of 131 I-huA 33 in Patientswith Advanced Colorectal Carcinoma
G. Chong, F. Lee, W. Hopkins, N. Tebbutt +18 more
200516 citations
Semantic Scholar
Improving outcomes for patients with lymphoma: design and development of the Australian and New Zealand Lymphoma and Related Diseases Registry
M. Anderson, L. Berkahn, Che-Ah Y. Chan, Michael Dickinson +62 more
2022BMC Medical Research Methodology15 citations Open access
Semantic Scholar
Quantitative intratumoural microdistribution and kinetics of 131I-huA33 antibody in patients with colorectal carcinoma
M. Ciprotti, G. Chong, Gan K. Hui, A. Chan +8 more
2014EJNMMI Research15 citations Open access
Semantic Scholar
Can cisplatin and infused 5-fluorouracil be replaced by oxaliplatin and capecitabine in the treatment of advanced oesophagogastric cancer? The REAL 2 trial.
G. Chong, David Cunningham
2005Clinics in oncology15 citations Open access
Semantic Scholar
Immune priming with avelumab and rituximab prior to R-CHOP in diffuse large B-cell lymphoma: the phase II AvR-CHOP study
K. Manos, G. Chong, C. Keane, Sze T. Lee +16 more
2023Leukemia14 citations
Semantic Scholar
Routine blood investigations have limited utility in surveillance of aggressive lymphoma in asymptomatic patients in complete remission
E. Hawkes, Z. Loh, O. Estacio, G. Chong +3 more
2018British Journal of Cancer14 citations Open access
Semantic Scholar
Tumour cell surface antigen targeted therapies in B-cell lymphomas: Beyond rituximab.
M. Ku, G. Chong, E. Hawkes
2017Blood reviews14 citations
Semantic Scholar
Phase II study of single-agent copanlisib in patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL).
G. Lenz, E. Hawkes, G. Verhoef, C. Haioun +14 more
201714 citations
Semantic Scholar
Gemcitabine, cisplatin and methylprednisolone (GEM-P) with or without Rituximab in relapsed and refractory patients with diffuse large B cell lymphoma (DLBCL)
B. Sirohi, D. Cunningham, A. Norman, K. Last +5 more
2007Hematology13 citations Open access
Semantic Scholar
Immune Priming with Single-Agent Nivolumab Followed By Combined Nivolumab & Rituximab Is Safe and Efficacious for First-Line Treatment of Follicular Lymphoma; Interim Analysis of the '1st FLOR' Study
A. Barraclough, G. Chong, M. Gilbertson, A. Grigg +10 more
2019Blood12 citations
Semantic Scholar
Utility of the Follicular Lymphoma International Prognostic Index and the International Prognostic Index in Assessing Prognosis and Predicting First-Line Treatment Efficacy in Follicular Lymphoma Patients
V. Formica, A. R. Norman, D. Cunningham, A. Wotherspoon +2 more
2009Acta Haematologica12 citations
Semantic Scholar
Outcomes in grade 3B follicular lymphoma: an international study led by the Australasian Lymphoma Alliance
A. Barraclough, J. England, D. Villa, J. Wight +26 more
2023Haematologica11 citations Open access
Semantic Scholar
Use of Ultrasonography Facilitates Noninvasive Evaluation of Lymphadenopathy in a Lymph Node Diagnostic Clinic.
Z. Loh, E. Hawkes, F. Chionh, A. Azad +1 more
2020Clinical Lymphoma, Myeloma & Leukemia11 citations
Semantic Scholar
Early Treatment Intensification with R-ICE Chemotherapy Followed By Autologous Stem Cell Transplantation (ASCT) Using Zevalin-BEAM for Patients with Poor Risk Diffuse Large B-Cell Lymphoma (DLBCL) As Identified By Interim PET/CT Scan Performed after Four
M. Hertzberg, M. Gandhi, B. Butcher, Ruth Columbus +21 more
201511 citations
Semantic Scholar
The role of cetuximab in the therapy of previously treated advanced colorectal cancer.
G. Chong, D. Cunningham
2005Seminars in Oncology10 citations
Semantic Scholar
Eculizumab therapy in gemcitabine-induced thrombotic microangiopathy in a renal transplant recipient.
Kylie Martin, V. Roberts, G. Chong, D. Goodman +2 more
2019Oxford Medical Case Reports9 citations Open access
Semantic Scholar
Comparison of radiologically inserted arm ports versus surgically placed chest ports for chemotherapy
Andrew Weickhardt, Timothy A Joseph, S. Shea, D. Arhanghelschi +3 more
20099 citations
Semantic Scholar
Dual Antiangiogenesis Agents Bevacizumab Plus Trebananib, without Chemotherapy, in First-line Treatment of Metastatic Colorectal Cancer: Results of a Phase II Study
J. Mooi, F. Chionh, P. Savas, J. da Gama Duarte +8 more
2021Clinical Cancer Research8 citations
Semantic Scholar
Bilateral papilledema on sunitinib therapy for advanced renal cell carcinoma
J. Yoong, G. Chong, Kate Hamilton
2011Medical Oncology8 citations
Semantic Scholar
Predicting primary treatment failure using interim FDG‐PET scanning in diffuse large B‐cell lymphoma
J. Wight, S. Wai, E. Shen, Sze T. Lee +6 more
2021European Journal of Haematology7 citations Open access
Semantic Scholar
Immune priming with nivolumab followed by nivolumab and rituximab in first-line treatment of follicular lymphoma: The phase 2 1st FLOR study.
E. Hawkes, Sze T. Lee, G. Chong, M. Gilbertson +12 more
20217 citations
Semantic Scholar
Ibrutinib Plus Venetoclax in Patients With Relapsed/Refractory Mantle Cell Lymphoma: Results From the Safety Run-In Period of the Phase 3 Sympatico Study
C. Tam, R. Ramchandren, Robert Chen, Lionel Karlin +12 more
2020Blood7 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

E. Hawkes×17
Invite
E. Hawkes — researcher profile on SciRah
A. Scott×9
Invite
A. Scott — researcher profile on SciRah
A. Grigg×9
Invite
A. Grigg — researcher profile on SciRah
A. Norman×7
Invite
A. Norman — researcher profile on SciRah

×7

Invite

A. Barraclough — researcher profile on SciRah

A. Wotherspoon×6

Invite

A. Wotherspoon — researcher profile on SciRah

Invite

F. Lee — researcher profile on SciRah

Invite

W. Hopkins — researcher profile on SciRah

Invite

N. Tebbutt — researcher profile on SciRah

Invite

J. Wight — researcher profile on SciRah

A. Papenfuss×5

Invite

A. Papenfuss — researcher profile on SciRah

Invite

F. Smyth — researcher profile on SciRah